Suppr超能文献

用8-苯胺基-1-萘磺酸盐探测尿激酶型纤溶酶原激活剂与其受体之间的配体相互作用。仅在完整受体上暴露疏水结合位点的证据。

Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor.

作者信息

Ploug M, Ellis V, Danø K

机构信息

Finsen Laboratory, Rigshospitalet, Copenhagen O, Denmark.

出版信息

Biochemistry. 1994 Aug 2;33(30):8991-7. doi: 10.1021/bi00196a017.

Abstract

The cellular receptor for urokinase-type plasminogen activator (uPAR) is a glycolipid-anchored membrane protein thought to play a primary role in the generation of pericellular proteolytic activity, and to be involved in cancer cell invasion and metastasis. This protein is composed of three homologous domains, the NH2-terminal of which is involved in the high-affinity binding (Kd approximately 0.1-1.0 nM) to the epidermal growth factor-like module of urokinase-type plasminogen activator (uPA). Here we report that intact uPAR binds the low molecular weight fluorophore 8-anilino-1-naphthalenesulfonate (ANS) to form a 1:1 stoichiometric complex and that the resulting enhancement of the ANS fluorescence probes the functional state of uPAR as judged by several independent criteria. First, the uPAR-mediated increase in ANS fluorescence can be titrated by uPA as well as by its receptor binding derivatives (the amino-terminal fragment and the growth factor-like module). Second, an anti-uPAR monoclonal antibody, capable of preventing uPA binding, can also titrate the uPAR-dependent ANS fluorescence whereas other antibodies not interfering with uPA binding are unable to exert this effect. Third, the dissociation profile of uPA-uPAR complexes as a function of increasing concentrations of guanidine hydrochloride closely parallels the loss of the ANS binding site in uPAR. Finally, liberation of the NH2-terminal domain from uPAR by limited chymotrypsin cleavage after Tyr87 leads to a loss of both enhanced ANS fluorescence and high-affinity uPA binding.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

尿激酶型纤溶酶原激活剂(uPAR)的细胞受体是一种糖脂锚定膜蛋白,被认为在细胞周围蛋白水解活性的产生中起主要作用,并参与癌细胞的侵袭和转移。该蛋白由三个同源结构域组成,其氨基末端参与与尿激酶型纤溶酶原激活剂(uPA)的表皮生长因子样模块的高亲和力结合(解离常数约为0.1 - 1.0 nM)。在此我们报告,完整的uPAR与低分子量荧光团8-苯胺基-1-萘磺酸盐(ANS)结合形成1:1化学计量复合物,并且由此产生的ANS荧光增强根据几个独立标准探测了uPAR的功能状态。首先,uPAR介导的ANS荧光增加可被uPA及其受体结合衍生物(氨基末端片段和生长因子样模块)滴定。其次,一种能够阻止uPA结合的抗uPAR单克隆抗体也能滴定uPAR依赖的ANS荧光,而其他不干扰uPA结合的抗体则无法发挥这种作用。第三,uPA - uPAR复合物的解离曲线作为盐酸胍浓度增加的函数与uPAR中ANS结合位点的丧失密切平行。最后,在Tyr87后通过有限的胰凝乳蛋白酶切割从uPAR释放氨基末端结构域导致增强的ANS荧光和高亲和力uPA结合均丧失。(摘要截短至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验